Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue
US11351167B2 · kind B2 · utility
1Cited by
33References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 26, 2019 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | Sep 15, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/485
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are provided herein for selectively killing senescent cells and for treating senescence-associated diseases and disorders by administering a senolytic agent. Senescence-associated diseases and disorders treatable by the methods using the senolytic agents described herein include cardiovascular diseases and disorders associated with or caused by arteriosclerosis, such as atherosclerosis; idiopathic pulmonary fibrosis; chronic obstructive pulmonary disease; osteoarthritis; senescence-associated ophthalmic diseases and disorders; and senescence-associated dermatological diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.